Turkish Adaptation of the VascuQoL-6 Quality of Life Scale
Launched by UŞAK UNIVERSITY · May 11, 2025
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Takayasu arteritis (TA) is a rare, systemic granulomatous large vessel vasculitis that primarily affects the aorta and its branches. Although all major arteries can be affected, the descending and ascending aorta, subclavian arteries, and carotid arteries are most commonly affected. Inflammation can lead to intimal proliferation and stenosis or destruction of the vascular structure and aneurysmal degeneration. TA is a disease with profound consequences on quality of life.
Behçet's disease is a multisystemic, chronic inflammatory vasculitis characterized by skin and mucosal lesions.
The va...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 18-65
- • Being willing to participate in the study
- • Being diagnosed with Takayasu Arteritis or Vascular Behçet's disease by a rheumatologist
- Exclusion Criteria:
- • Having another disease that will affect their physical condition
- • Having a cognitive disability that will prevent them from cooperating
- • Being pregnant
- • Having a neurological disease (hemiplegia, Parkinson's, multiple sclerosis, vertigo, epilepsy, etc.)
- • Having undergone any surgery in the last year
- • Having another simultaneous rheumatic disease
About Uşak University
Uşak University is a distinguished academic institution dedicated to advancing research and education in various fields, including the health sciences. As a clinical trial sponsor, Uşak University is committed to fostering innovation and contributing to medical knowledge through rigorous scientific investigation. The university collaborates with healthcare professionals and researchers to conduct high-quality clinical trials that aim to improve patient outcomes and enhance therapeutic interventions. With a focus on ethical standards and regulatory compliance, Uşak University strives to ensure the integrity and reliability of its research initiatives, ultimately benefiting the broader community and the advancement of healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, , Turkey
Denizli, , Turkey
Patients applied
Trial Officials
Bilge Basakcı Calık, Prof. Dr.
Principal Investigator
Pamukkale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported